Age-related Cognitive Decline Clinical Trials
3 recruiting trials for Age-related Cognitive Decline. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Age-related Cognitive Decline clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Georgetown University (1), University of Southern California (1), University of Tasmania (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Daily practice (behavioral, 1 trial), followed by Cognitive test scores, clinical diagnosis and blood biomarkers.
Track Age-related Cognitive Decline trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Older Breast Cancer Patients: Risk for Cognitive Decline
The goal of this study is to evaluate the impact of systemic therapy on cognition in older breast cancer patients, explore change in APE, LM and Cognition domains, measure...
Cardiac-Control Affecting Learning Through Mindfulness (CALM)
Some types of meditation lead heart rate to become more steady as breathing quiets whereas others lead to large heart rate swings up and down (oscillations) as breathing becomes...
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
Global dementia prevalence is rising. Alzheimer's disease (AD), the most common cause, has devastating effects on people's quality of life. AD has a preclinical (pre-AD) period of...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Age-related Cognitive Decline, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Age-related Cognitive Decline, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Age-related Cognitive Decline, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.